Jill Jene

2019

In 2019, Jill Jene earned a total compensation of $1.2M as Vice President, Business Development at PDL BioPharma, a 61% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$280,707
Option Awards$600,000
Salary$350,200
Other$10,000
Total$1,240,907

Jene received $600K in option awards, accounting for 48% of the total pay in 2019.

Jene also received $280.7K in non-equity incentive plan, $350.2K in salary and $10K in other compensation.

Rankings

In 2019, Jill Jene's compensation ranked 8,256th out of 13,971 executives tracked by ExecPay. In other words, Jene earned more than 40.9% of executives.

ClassificationRankingPercentile
All
8,256
out of 13,971
41st
Division
Manufacturing
3,256
out of 5,701
43rd
Major group
Chemicals And Allied Products
1,233
out of 2,200
44th
Industry group
Drugs
1,047
out of 1,886
45th
Industry
Biological Products, Except Diagnostic Substances
236
out of 389
39th
Source: SEC filing on July 7, 2020.

Jene's colleagues

We found four more compensation records of executives who worked with Jill Jene at PDL BioPharma in 2019.

2019

Dominique Monnet

PDL BioPharma

Chief Executive Officer

2019

Peter Garcia

PDL BioPharma

Chief Financial Officer

2019

Christopher Stone

PDL BioPharma

General Counsel

2019

Edward Imbrogno

PDL BioPharma

Chief Financial Officer

News

You may also like